Pomalidomide in Refractory Multiple Myeloma In this segment, Noopur Raje, MD, Sagar Lonial, MD, and Ann McNeill, RN, APN, discuss the role of pomalidomide in therapy for patients with multiple myeloma, as well as the toxicities and adverse reactions associated with pomalidomide therapy. Get more expert insight, at http://www.onclive.com/insights/myeloma
Read More
Evaluating Teclistamab in Relapsed and/or Refractory Multiple Myeloma Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM) Background: MM inevitably relapses and becomes refractory to treatment, representing a patient (pt) population with unmet needs. Teclistamab (JNJ-64007957) is a bispecific BCMA x CD3 […]
Read More
How is nonsecretory multiple myeloma diagnosed? Dr. Philippe Moreau discusses diagnosing multiple myeloma in a patient that is not secreting proteins but presents with CRAB symptoms. Join our online communities to begin receiving free continuing medical education (CME) credit today! Managing Myeloma: http://www.managingmyeloma.com/ Managing Hodgkin Lymphoma: http://www.managinghodgkinlymphoma.com/ Managing MDS: http://www.managingmds.com/ Managing CML: http://www.managingcml.com/ Partners in […]
Read More
Grand View Research.com has announced the addition of “North America Polyurethane (PU) Market Analysis and Segment Forecasts To 2020” Market Research report to their Database. The North America Polyurethane (PU) Market is expected to reach USD 14.46 billion by 2020, according to a new study by Grand View Research, Inc. Growing importance for energy efficiency on account of […]
Read More
Lyme disease is an infection which occurs when a tick bites a person and transfers Lyme bacteria inside the person’s body. There are various types of Lyme disease symptoms which can be divided into three different categories. Lyme disease is the most common tick-borne illness in Europe, USA and Australia. People who live or spend […]
Read More
Ask the Multiple Myeloma Experts Summary: The current standard of care for patients with multiple myeloma is high dose chemotherapy and an autologous stem cell transplant. Although an autologous transplant is not a cure, maintenance therapy with various drugs can control myeloma in many patients for several years. Panelists: Jens Hillengass MD, Chief of Myeloma, […]
Read More
Degenerative Disc Disease (DDD) isn’t actually a disease, instead, it’s a name given for discs that have become degenerated over time from normal wear and tear. For your convenience, we will stay consistent and use that incorrect terminology, but we want you to recognize that it’s not a disease. Whenever DDD is given as a […]
Read More
When my own dog was diagnosed with the condition [liver condition], I know the entire situation could have been handled much better had I taken the time to educate myself and taken the steps necessary early on to help him to his full recovery. My dog has since made a full recovery from jus a […]
Read More
Grand View Research.com has announced the addition of “Oncology Molecular Diagnostics Market Analysis and Segment Forecasts To 2022” Market Research report to their Database. Global oncology based molecular diagnostics market is expected to reach USD 3,391.0 million by 2022 according to a new report by Grand View Research Inc. The rising geriatric population base, increasing global prevalence […]
Read More ”; What Is It?The kidney disease diet is designed to give your kidneys a sufficient rest so that they can rebuild from the inside out. This is not a diet that flushes your system like many of the detoxifying or cleansing diets do. In fact, that is actually the last thing that you want to […]
Read More